Beaumont Financial Partners LLC lifted its stake in Danaher Co. (NYSE:DHR – Get Rating) by 2.6% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 50,032 shares of the conglomerate’s stock after buying an additional 1,265 shares during the quarter. Danaher makes up 1.1% of Beaumont Financial Partners LLC’s holdings, making the stock its 24th largest position. Beaumont Financial Partners LLC’s holdings in Danaher were worth $14,682,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also recently modified their holdings of the stock. City Holding Co. boosted its position in Danaher by 13.0% during the first quarter. City Holding Co. now owns 4,133 shares of the conglomerate’s stock worth $1,212,000 after purchasing an additional 475 shares in the last quarter. RDA Financial Network raised its holdings in shares of Danaher by 73.4% during the first quarter. RDA Financial Network now owns 2,763 shares of the conglomerate’s stock valued at $810,000 after acquiring an additional 1,170 shares during the last quarter. Wambolt & Associates LLC raised its holdings in shares of Danaher by 5.1% during the fourth quarter. Wambolt & Associates LLC now owns 1,035 shares of the conglomerate’s stock valued at $341,000 after acquiring an additional 50 shares during the last quarter. Selective Wealth Management Inc. raised its holdings in shares of Danaher by 500.0% during the first quarter. Selective Wealth Management Inc. now owns 348 shares of the conglomerate’s stock valued at $102,000 after acquiring an additional 290 shares during the last quarter. Finally, 1900 Wealth Management LLC raised its holdings in shares of Danaher by 2.6% during the first quarter. 1900 Wealth Management LLC now owns 1,969 shares of the conglomerate’s stock valued at $578,000 after acquiring an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 78.42% of the company’s stock.
Analyst Upgrades and Downgrades
DHR has been the subject of a number of research analyst reports. William Blair reissued an “outperform” rating on shares of Danaher in a report on Friday, April 22nd. StockNews.com raised Danaher from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 30th. Cowen cut their price target on Danaher to $340.00 in a report on Friday, July 22nd. Wells Fargo & Company cut Danaher from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $330.00 to $265.00 in a report on Monday, April 25th. Finally, Evercore ISI cut their price target on Danaher from $320.00 to $280.00 and set an “outperform” rating for the company in a report on Tuesday, July 5th. One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Danaher presently has an average rating of “Buy” and a consensus target price of $328.58.
Insider Buying and Selling at Danaher
Danaher Stock Up 0.4 %
NYSE:DHR traded up $1.05 during midday trading on Friday, reaching $290.00. The company had a trading volume of 1,316,343 shares, compared to its average volume of 2,304,426. The firm has a market capitalization of $210.96 billion, a price-to-earnings ratio of 34.16, a PEG ratio of 2.32 and a beta of 0.86. The stock’s fifty day simple moving average is $261.98 and its 200-day simple moving average is $268.32. Danaher Co. has a 12-month low of $233.71 and a 12-month high of $333.96. The company has a current ratio of 1.75, a quick ratio of 1.32 and a debt-to-equity ratio of 0.45.
Danaher (NYSE:DHR – Get Rating) last released its earnings results on Thursday, July 21st. The conglomerate reported $2.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.35 by $0.41. The firm had revenue of $7.75 billion during the quarter, compared to analyst estimates of $7.29 billion. Danaher had a return on equity of 18.57% and a net margin of 20.61%. Danaher’s revenue was up 7.4% compared to the same quarter last year. During the same period last year, the business posted $2.46 earnings per share. On average, sell-side analysts anticipate that Danaher Co. will post 10.39 earnings per share for the current fiscal year.
Danaher Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, July 29th. Shareholders of record on Friday, June 24th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date of this dividend was Thursday, June 23rd. Danaher’s dividend payout ratio is presently 11.78%.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.
- Get a free copy of the StockNews.com research report on Danaher (DHR)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.